Affiliations 

  • 1 K L Khoo, FRCP. Klinik Dr Khoo Kah Lin, 25, Jalan Medan Tuanku, 50300 Kuala Lumpur
  • 2 Dept of Endocrinology, State University, De Pintelaan 185, Ghent, Belgium
  • 3 H Tan, PhD. Heart Foundation Malaysia, 35,Jalan Kia Peng, 50450 Kuala Lumpur
  • 4 J P Deslypere, MD, PhD. BO Analytical Research Corporation, Industrie Park Zwiinaarde, 7 Box 3, B-9052, Ghent, Belgium
Med J Malaysia, 2000 Dec;55(4):409-18.
PMID: 11221151

Abstract

A total of 86 unrelated Malaysian patients with familial hypercholesterolaemia (FH) were studied for mutations in their low-density lipoprotein receptor (LDL-R) gene. Amongst them, 23 had a LDL-R gene mutation, while none having an Apolipoprotein B-3500 (Apo B-3500) mutation. Patients with the LDL-R gene defect appeared to have a higher level of low-density lipoprotein cholesterol (LDL-C), an increased incidence of xanthomas and coronary heart disease (CHD), but no relationships were found between the type of LDL-R gene mutations and their lipid levels or clinical signs of CHD. In contrast to Western data, our findings seemed to indicate a predominance of mutations in the ligand binding domain and an absence of Apo B-3500 gene mutation. The latter finding may offer a genetic basis as to why Asian patients with familial hypercholesterolaemia have lower LDL-C levels and less premature CHD than their Western counterparts.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.